LINEAR HYALURONIC ACID

An injectable, non-pyrogenic, reabsorbable Medical Device containing linear Hyaluronic Acid of non-animal origin, produced via bacterial fermentation. The product presents itself as a colorless gel contained in a pre-filled, graduated, disposable and sterile glass syringe with a Luer Lok adapter

VANTAGGIADVANTAGES:

• Hypersensivity reactions are minimized by high purity, low concentration of nucleic acids, proteins and endotoxins (≤ 0,5 EU/ml much lower than the limits of toleration indicated by European Pharmacopoeia for injectables)
• Four different concentrations allow physicians to perform customized treatments.

ACTION:

Hyaluronic acid promotes the viscoelastic properties of the synovial fluid. In degenerative joint pathologies such as chronic primary osteoarthritis, synovial fluid has a reduced viscosity, decreasing the joint’s shock absorption ability and lubrication. Intra-articular injections promote, through the natural ability of hyaluronic acid molecules’ to bind to a quantity of water that is many times higher than their weight, the restoration of the natural lubrication of synovial fluid. As a result, overall mobility and joint function are improved reducing mechanical joint overload and painful syntoms.

DIRECTIONS:

Intra-articular treatment for pain and/or reduced mobility due to traumatic or degenerative deformities of the knee or synovial joints.

PROTOCOLS OF USE:

Intra-articular injections must be performed using a spinal needle ranging between 18G and 21G. Use a needle of a suitable length for treating the joint. The intra-articular infiltration must be performed solely by qualified medical personnel. Take all the normal precautions for intra-articular injections. This product must be used with caution in the event of lymphatic or venous stasis in the leg to be treated. In the event of joint effusion, we recommend its reduction through aspiration, rest, and application of an ice pack. In this instance, we recommend starting the treatment 2 or 3 days later.

Our CE marked medical devices.
INTRA-ARTICULAR MEDICAL DEVICES
CROSS-LINKED HYALURONIC ACID
AESTHETIC MEDICAL DEVICES
CROSS-LINKED HYALURONIC ACID WITH BDDE
CROSS-LINKED HYALURONIC ACID WITH DVS
LINEAR HYALURONIC ACID
POLYNUCLEOTIDES GEL
Placing products on the market IRA medical devices can be subject to the licence of the CE marked product or subsequent private label agreements with partner companies.
Operatore in camice e guanti controlla fiale in vetro su una linea produttiva sterile
Production of raw materials for pharmaceuticals and cosmetics.
Tecnico di laboratorio visto di spalle mentre analizza dati scientifici su due monitor, in laboratorio con strumentazione e bottiglie di reagenti chimici sullo sfondo.
There’s a lot we can do together Get in touch. We’re at your service.
© IRA Istituto Ricerche Applicate S.p.A. | Registro imprese C.C.I.A.A. n. 1120295 - C.Fisc. 06775360156 - P.Iva IT00836940965 | Privacy Policy | Cookie Policy | Internal Privacy Policy